Trastuzumab vs Vedolizumab

## Trastuzumab vs Vedolizumab: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Vedolizumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Vedolizumab — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Vedolizumab — Antibody.